Drug Profile
Research programme: insulin-like growth factor receptor antagonists - AbbVie
Alternative Names: A 923573; A-923573.7; A-928605Latest Information Update: 24 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Class Pyrazoles; Pyrimidines
- Mechanism of Action Insulin-like growth factor-I receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 07 Nov 2007 Preclinical trials in Cancer in USA (unspecified route)